Thrombosis and bleeding disorders outside Western countries

Journal of Thrombosis and Haemostasis

Volumn 5, Issue SUPPL. 1, 2007, Pages 68-72

  Mannucci, Pier M ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE   (Italy)

Author keywords

Hemophilia; India; Iran; Recessive bleeding disorders; Thailand; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR CONCENTRATE; PLACEBO;

AFRICAN AMERICAN; ASIA; AWARENESS; BIOTECHNOLOGY; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CAUCASIAN; CHINA; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DEVELOPING COUNTRY; DOPPLER ECHOGRAPHY; GENE TRANSFER; HEALTH CARE AVAILABILITY; HEALTH PROGRAM; HEMOPHILIA A; HEMOPHILIA B; HIGH RISK PATIENT; HISPANIC; HUMAN; INDIA; LEADERSHIP; LUNG EMBOLISM; ORTHOPEDIC SURGERY; PACIFIC ISLANDER; PATIENT CARE; PHLEBOGRAPHY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SURGICAL PATIENT; THAILAND; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

ASIA; BLOOD COAGULATION DISORDERS; DEVELOPING COUNTRIES; HUMANS; THROMBOSIS;

EID: 34250785773     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02463.x     Document Type: Review

References (28)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9.
2. Ho CH, Chau WK, Hsu HC, Gau JP, Yu TJ. Causes of venous thrombosis in fifty Chinese patients. Am J Hematol 2000; 63: 74-8.
3. Shen MC, Lin JS, Tsay W. Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 2000; 99: 447-52.
4. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
5. Stein PD, Kayali F, Olson RE, Milford CE. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: Analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004; 116: 435-42.
6. Leizorovicz A, Turpie AGG, Cohen AT, Dhillon KS, Anychaisuksiri P, Wang CJ, for the SMART Study Group. Epidemiology of post-operative venous thromboembolism in Asian countries. Int J Angiol 2004; 13: 101-8.
7. Leizorovicz A, Turpie AGG, Cohen AT, Wong L, Yoo MC, Dans A. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost 2005; 3: 28-34.
8. Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, Turpie AG, Gallus AS, Planes A, Passera R, Rouillon A. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 2005; 3: 2664-70.
9. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338s-400s.
10. Cheng Y, Wong R, Lam J, Lau FY, Cheng G. Estimated risk of deep venous thrombosis among Chinese patients admitted to general medical wards. J Thromb Haemost 2004; 2: 1666-8.
11. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999; 82: 1207-14.
12. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-1252.
13. Peyvandi F, Kaufman RJ, Seligsohn U, Salomon O, Bolton-Maggs PH, Spreafico M, Menegatti M, Palla R, Siboni S, Mannucci PM. Rare bleeding disorders. Haemophilia 2006; 12 (Suppl. 3): 137-42.
14. Nelson EJ, Nair SC, Peretz H, Coller BS, Seligsohn U, Chandy M, Srivastava A. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients. J Thromb Haemost 2006; 4: 1730-7.
15. Peretz H, Rosenberg N, Landau M, Usher S, Nelson EJ, Mor-Cohen R, French DL, Mitchell BW, Nair SC, Chandy M, Coller BS, Srivastava A, Seligsohn U. Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3). Hum Mutat 2006; 27: 359-69.
16. Mannucci PM. International clinical experience with plasma-derived factor VIII and factor IX concentrates. Haematologica 2006; 91(s3): 26-31.
17. Kasper CK. Products for clotting factor replacement in developing countries. Semin Thromb Hemost 2005; 31: 507-12.
18. Chuansumrit A, Krasaesub S, Angchaisuksiri P, Hathirat P, Isarangkura P. Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand. Haemophilia 2004; 10: 542-9.
19. Chuansumrit A. Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia. J Thromb Haemost 2003; 1: 396.
20. Sirachainan N, Chuansumrit A, Hanutsaha P, Pakakasama S, Hongeng S. Preserving eye function in prematurely born children with severe protein C deficiency. J Thromb Haemost 2003; 1: 1858-9.
21. Srivastava A. Delivery of haemophilia care in the developing world. Haemophilia 1998; 4: 33-40.
22. Jayandharan G, Nelson EJ, Baidya S, Chandy M, Srivastava A. A new multiplex PCR and conformation sensitive gel electrophoresis strategy for mutation detection in the platelet glycoprotein alphabeta genes. J Thromb Haemost 2007; 5: 206-9.
23. Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, George B, Chandy M, Srivastava A. Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T→G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin. J Thromb Haemost 2005; 3: 1482-7.
24. Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, Chandy M, Srivastava A. Molecular genetics of hereditary prothrombin deficiency in Indian patients: Identification of a novel Ala362→Thr (Prothrombin Vellore 1) mutation. J Thromb Haemost 2005; 3: 1446-53.
25. Nair S, Ghosh K, Shetty S, Mohanty D. Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients. J Thromb Haemost 2005; 3: 482-8.
26. Ghosh K, Shetty S, Mohanty D. Inversion of intron 1 is a rare cause of severe hemophilia A in Indian population. J Thromb Haemost 2004; 2: 1481-2.
27. Hertzberg MS, Mammen J, McCraw A, Nair SC, Srivastava A. Achieving and maintaining quality in the laboratory. Haemophilia 2006; 12: 61-7.
28. Qiu X, Lu D, Zhou J. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Chin Med J 1996; 109: 832-839.